Búsqueda | Portal de Búsqueda de la BVS España

1.

SAPPHIRE: phase III study of sitravatinib plus nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer.

Borghaei, H; de Marinis, F; Dumoulin, D; Reynolds, C; Theelen, W S M E; Percent, I; Gutierrez Calderon, V; Johnson, M L; Madroszyk-Flandin, A; Garon, E B; He, K; Planchard, D; Reck, M; Popat, S; Herbst, R S; Leal, T A; Shazer, R L; Yan, X; Harrigan, R; Peters, S.

Ann Oncol; 35(1): 66-76, 2024 Jan.

Artículo en Inglés | MEDLINE | ID: mdl-37866811

2.

Amivantamab plus chemotherapy with and without lazertinib in EGFR-mutant advanced NSCLC after disease progression on osimertinib: primary results from the phase III MARIPOSA-2 study.

Passaro, A; Wang, J; Wang, Y; Lee, S-H; Melosky, B; Shih, J-Y; Wang, J; Azuma, K; Juan-Vidal, O; Cobo, M; Felip, E; Girard, N; Cortot, A B; Califano, R; Cappuzzo, F; Owen, S; Popat, S; Tan, J-L; Salinas, J; Tomasini, P; Gentzler, R D; William, W N; Reckamp, K L; Takahashi, T; Ganguly, S; Kowalski, D M; Bearz, A; MacKean, M; Barala, P; Bourla, A B; Girvin, A; Greger, J; Millington, D; Withelder, M; Xie, J; Sun, T; Shah, S; Diorio, B; Knoblauch, R E; Bauml, J M; Campelo, R G; Cho, B C.

Ann Oncol; 35(1): 77-90, 2024 Jan.

Artículo en Inglés | MEDLINE | ID: mdl-37879444

3.

Concurrent oral delivery of non-oncology drugs through solid self-emulsifying system for repurposing in hepatocellular carcinoma.

Ardad, Rameshwar M; Manjappa, Arehalli S; Dhawale, Shashikant C; Kumbhar, Popat S; Pore, Yogesh V.

Drug Dev Ind Pharm; 49(5): 377-391, 2023 Dec.

Artículo en Inglés | MEDLINE | ID: mdl-37216496

4.

Nanostructured Lipid Carrier-Based Gel for Repurposing Simvastatin in Localized Treatment of Breast Cancer: Formulation Design, Development, and In Vitro and In Vivo Characterization.

Kumbhar, Popat S; Manjappa, Arehalli S; Shah, Rohit R; Nadaf, Sameer J; Disouza, John I.

AAPS PharmSciTech; 24(5): 106, 2023 Apr 21.

Artículo en Inglés | MEDLINE | ID: mdl-37085596

5.

First-line nivolumab plus ipilimumab versus chemotherapy in patients with unresectable malignant pleural mesothelioma: 3-year outcomes from CheckMate 743.

Ann Oncol; 33(5): 488-499, 2022 05.

Artículo en Inglés | MEDLINE | ID: mdl-35124183

6.

ESMO recommendations on the use of circulating tumour DNA assays for patients with cancer: a report from the ESMO Precision Medicine Working Group.

Pascual, J; Attard, G; Bidard, F-C; Curigliano, G; De Mattos-Arruda, L; Diehn, M; Italiano, A; Lindberg, J; Merker, J D; Montagut, C; Normanno, N; Pantel, K; Pentheroudakis, G; Popat, S; Reis-Filho, J S; Tie, J; Seoane, J; Tarazona, N; Yoshino, T; Turner, N C.

Ann Oncol; 33(8): 750-768, 2022 08.

Artículo en Inglés | MEDLINE | ID: mdl-35809752

7.

Consolidation nivolumab and ipilimumab versus observation in limited-disease small-cell lung cancer after chemo-radiotherapy - results from the randomised phase II ETOP/IFCT 4-12 STIMULI trial.

Peters, S; Pujol, J-L; Dafni, U; Dómine, M; Popat, S; Reck, M; Andrade, J; Becker, A; Moro-Sibilot, D; Curioni-Fontecedro, A; Molinier, O; Nackaerts, K; Insa Mollá, A; Gervais, R; López Vivanco, G; Madelaine, J; Mazieres, J; Faehling, M; Griesinger, F; Majem, M; González Larriba, J L; Provencio Pulla, M; Vervita, K; Roschitzki-Voser, H; Ruepp, B; Mitchell, P; Stahel, R A; Le Pechoux, C; De Ruysscher, D.

Ann Oncol; 33(1): 67-79, 2022 01.

Artículo en Inglés | MEDLINE | ID: mdl-34562610

8.

ESMO expert consensus statements on the management of EGFR mutant non-small-cell lung cancer.

Passaro, A; Leighl, N; Blackhall, F; Popat, S; Kerr, K; Ahn, M J; Arcila, M E; Arrieta, O; Planchard, D; de Marinis, F; Dingemans, A M; Dziadziuszko, R; Faivre-Finn, C; Feldman, J; Felip, E; Curigliano, G; Herbst, R; Jänne, P A; John, T; Mitsudomi, T; Mok, T; Normanno, N; Paz-Ares, L; Ramalingam, S; Sequist, L; Vansteenkiste, J; Wistuba, I I; Wolf, J; Wu, Y L; Yang, S R; Yang, J C H; Yatabe, Y; Pentheroudakis, G; Peters, S.

Ann Oncol; 33(5): 466-487, 2022 05.

Artículo en Inglés | MEDLINE | ID: mdl-35176458

9.

Interplay of Anion-π⁺ and π⁺ -π⁺ Interactions in Novel Pyrido[2,1-a]isoquinolinium-Based AIEgens - Substituent- and Counterion-Dependent Fluorescence Modulation and Applications in Live Cell Mitochondrial Imaging.

Mule, Ravindra D; Roy, Rupam; Mandal, Koushik; Chopra, Deepak; Dutta, Tanoy; Sancheti, Shashank P; Shinde, Popat S; Banerjee, Somsuvra; Lal Koner, Apurba; Bhowal, Rohit; Senthilkumar, Beeran; Patil, Nitin T.

Chemistry; 28(38): e202200632, 2022 Jul 06.

Artículo en Inglés | MEDLINE | ID: mdl-35429368

10.

A multicentre randomised phase III trial comparing pembrolizumab versus single-agent chemotherapy for advanced pre-treated malignant pleural mesothelioma: the European Thoracic Oncology Platform (ETOP 9-15) PROMISE-meso trial.

Popat, S; Curioni-Fontecedro, A; Dafni, U; Shah, R; O'Brien, M; Pope, A; Fisher, P; Spicer, J; Roy, A; Gilligan, D; Gautschi, O; Nadal, E; Janthur, W D; López Castro, R; García Campelo, R; Rusakiewicz, S; Letovanec, I; Polydoropoulou, V; Roschitzki-Voser, H; Ruepp, B; Gasca-Ruchti, A; Peters, S; Stahel, R A.

Ann Oncol; 31(12): 1734-1745, 2020 12.

Artículo en Inglés | MEDLINE | ID: mdl-32976938

11.

Immune checkpoint inhibitors for patients with advanced lung cancer and oncogenic driver alterations: results from the IMMUNOTARGET registry.

Mazieres, J; Drilon, A; Lusque, A; Mhanna, L; Cortot, A B; Mezquita, L; Thai, A A; Mascaux, C; Couraud, S; Veillon, R; Van den Heuvel, M; Neal, J; Peled, N; Früh, M; Ng, T L; Gounant, V; Popat, S; Diebold, J; Sabari, J; Zhu, V W; Rothschild, S I; Bironzo, P; Martinez-Marti, A; Curioni-Fontecedro, A; Rosell, R; Lattuca-Truc, M; Wiesweg, M; Besse, B; Solomon, B; Barlesi, F; Schouten, R D; Wakelee, H; Camidge, D R; Zalcman, G; Novello, S; Ou, S I; Milia, J; Gautschi, O.

Ann Oncol; 30(8): 1321-1328, 2019 08 01.

Artículo en Inglés | MEDLINE | ID: mdl-31125062

12.

Adjuvant immune checkpoint inhibitor therapy for resected non-small-cell lung cancer: dessert, starters, or a sandwich?

John, A; Popat, S.

Ann Oncol; 34(10): 829-830, 2023 10.

Artículo en Inglés | MEDLINE | ID: mdl-37777306

13.

Gold(i)-catalyzed cross-coupling reactions of aryldiazonium salts with organostannanes.

Akram, Manjur O; Shinde, Popat S; Chintawar, Chetan C; Patil, Nitin T.

Org Biomol Chem; 16(16): 2865-2869, 2018 04 25.

Artículo en Inglés | MEDLINE | ID: mdl-29632948

14.

Catalytic Enantioselective 1,3-Alkyl Shift in Alkyl Aryl Ethers: Efficient Synthesis of Optically Active 3,3'-Diaryloxindoles.

Gade, Amol B; Bagle, Pradip N; Shinde, Popat S; Bhardwaj, Vipin; Banerjee, Subhrashis; Chande, Ajit; Patil, Nitin T.

Angew Chem Int Ed Engl; 57(20): 5735-5739, 2018 05 14.

Artículo en Inglés | MEDLINE | ID: mdl-29573526

15.

Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up^â.

Popat, S; Baas, P; Faivre-Finn, C; Girard, N; Nicholson, A G; Nowak, A K; Opitz, I; Scherpereel, A; Reck, M.

Ann Oncol; 33(2): 129-142, 2022 02.

Artículo en Inglés | MEDLINE | ID: mdl-34861373

16.

A randomised assessment of the use of a quality of life questionnaire with or without intervention in patients attending a thoracic cancer clinic.

Nimako, K; Ayite, B; Priest, K; Severn, J; Fries, H M; Gunapala, R; Bhosle, J; Popat, S; O'Brien, M.

Eur J Cancer Care (Engl); 26(4)2017 Jul.

Artículo en Inglés | MEDLINE | ID: mdl-26556778

17.

Brain metastases in solid tumours: new guidelines for a new era.

Popat, S; Welsh, L.

Ann Oncol; 32(11): 1322-1324, 2021 11.

Artículo en Inglés | MEDLINE | ID: mdl-34455070

18.

The National Lung Matrix Trial: translating the biology of stratification in advanced non-small-cell lung cancer.

Middleton, G; Crack, L R; Popat, S; Swanton, C; Hollingsworth, S J; Buller, R; Walker, I; Carr, T H; Wherton, D; Billingham, L J.

Ann Oncol; 26(12): 2464-9, 2015 Dec.

Artículo en Inglés | MEDLINE | ID: mdl-26410619

19.

Randomized, phase III trial of figitumumab in combination with erlotinib versus erlotinib alone in patients with nonadenocarcinoma nonsmall-cell lung cancer.

Scagliotti, G V; Bondarenko, I; Blackhall, F; Barlesi, F; Hsia, T-C; Jassem, J; Milanowski, J; Popat, S; Sanchez-Torres, J M; Novello, S; Benner, R J; Green, S; Molpus, K; Soria, J-C; Shepherd, F A.

Ann Oncol; 26(3): 497-504, 2015 Mar.

Artículo en Inglés | MEDLINE | ID: mdl-25395283

20.

Assessing standardization of molecular testing for non-small-cell lung cancer: results of a worldwide external quality assessment (EQA) scheme for EGFR mutation testing.

Patton, S; Normanno, N; Blackhall, F; Murray, S; Kerr, K M; Dietel, M; Filipits, M; Benlloch, S; Popat, S; Stahel, R; Thunnissen, E.

Br J Cancer; 111(2): 413-20, 2014 Jul 15.

Artículo en Inglés | MEDLINE | ID: mdl-24983368

Portal de Búsqueda de la BVS España

Información y Conocimiento para la Salud

Configurar filtros

Su selección (0)

Formato de exportación:

Exportar: